Pneumococcal polysaccharide vaccine 23-valent (Beijing Minhai Biotechnology)

23价肺炎球菌多糖疫苗（北京民海生物科技有限公司）

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePneumococcal polysaccharide vaccine 23-valent (Beijing Minhai Biotechnology)
Drug Alias Name23-valent pneumococcal polysaccharide vaccine(Beijing Minhai Biotechnology)
ClassificationVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMeningitisEncephalitisOtitis Media +[6] 
Global Approved IndicationsMeningitisOtitis MediaPneumonia +[4] 
Approved Indications in ChinaMeningitisOtitis MediaPneumonia +[4] 
Original Approved Country/TerritoryMainland China
Original Approved Date2018/08/12
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBeijing Minhai Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Minhai Biotechnology Co Ltd
Inactive CompaniesGenentech Inc
Active IndicationsMeningitisOtitis MediaPneumonia +[4] 
Inactive IndicationsEncephalitisArthritis, Rheumatoid

Other Information

ATC CodeJ07AL01
Related LinksN/A